Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.42 |
| ▸ | HTR3B | O95264 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.42 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.42 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 4/20 | 0.39 |
| ▸ | MAOB | P27338 | 4/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15349388 | 0.81 | HTR3E (0.38) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL16921374 | 0.77 | ALKBH5 (0.51) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL16863653 | 0.74 | TDP1 (0.43) | CYP1A2CYP2C19KDM4EPOLBNPC1 | |
| SCHEMBL16871672 | 0.73 | KDM4E (0.47) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL16871419 | 0.72 | CDK5 (0.36) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL9138426 | 0.70 | HTR3E (0.52) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL362986 | 0.70 | HTR3E (0.56) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL29792929 | 0.70 | NPC1 (0.41) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL10099727 | 0.70 | HTR3E (0.52) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL8797846 | 0.69 | ADORA3 (0.54) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11145829-B2 | Organic electroluminescent device, organic electroluminescent display device including the same, and organometallic compound for organic electroluminescent device | SAMSUNG DISPLAY CO., LTD. | 2021-10-12 | — | — | US | disclosed |
| US-20190245154-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE INCLUDING THE SAME, AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-08 | — | — | US | disclosed |
| US-8987451-B2 | Synthesis of cyclometallated platinum(II) complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2015-03-24 | — | — | US | disclosed |
| US-20150076466-A1 | BLUE LUMINESCENT COMPOUNDS | E. I. DUPONT DE NEMOURS AND COMPANY | 2015-03-19 | — | — | US | disclosed |
| US-20150076466-A1 | BLUE LUMINESCENT COMPOUNDS | E. I. DUPONT DE NEMOURS AND COMPANY | 2015-03-19 | — | — | US | disclosed |
| US-20150076466-A1 | BLUE LUMINESCENT COMPOUNDS | E. I. DUPONT DE NEMOURS AND COMPANY | 2015-03-19 | — | — | US | disclosed |
| EP-2841442-A1 | BLUE LUMINESCENT COMPOUNDS | E. I. Du Pont de Nemours and Company (US) | 2015-03-04 | — | — | EP | disclosed |
| WO-2013163022-A1 | BLUE LUMINESCENT COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| WO-2013163022-A1 | BLUE LUMINESCENT COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130172561-A1 | SYNTHESIS OF CYCLOMETALLATED PLATINUM(II) COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| JP-2010215759-A | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY, LIGHTING DEVICE, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT | KONICA MINOLTA HOLDINGS INC | 2010-09-30 | — | — | JP | disclosed |
| EP-1494673-B1 | COMPOUNDS HAVING UNIQUE CB1 RECEPTOR BINDING SELECTIVITY AND METHODS FOR THEIR PRODUCTION AND USE | RES TRIANGLE INST (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1494673-A4 | COMPOUNDS HAVING UNIQUE CB1 RECEPTOR BINDING SELECTIVITY AND METHODS FOR THEIR PRODUCTION AND USE | RES TRIANGLE INST (US) | 2006-01-18 | — | — | EP | disclosed |
| EP-1494673-A1 | COMPOUNDS HAVING UNIQUE CB1 RECEPTOR BINDING SELECTIVITY AND METHODS FOR THEIR PRODUCTION AND USE | RESEARCH TRIANGLE INSTITUTE (US) | 2005-01-12 | — | — | EP | disclosed |
| US-6825209-B2 | AN AMIDE DERIVATIVE USED AS CANNABINOID ANTAGONIST FOR THE TREATMENT OF OBESITY, SCHIZOPHRENIA, MEMORY DYSFUNCTION AND MARIJUANA ABUSE | RESEARCH TRIANGLE INSTITUTE | 2004-11-30 | — | — | US | disclosed |
| WO-2003088968-A1 | COMPOUNDS HAVING UNIQUE CB1 RECEPTOR BINDING SELECTIVITY AND METHODS FOR THEIR PRODUCTION AND USE | RESEARCH TRIANGLE INSTITUTE (US) | 2003-10-30 | — | — | WO | disclosed |
| US-20030199536-A1 | Compounds having unique CB1 receptor binding selectivity and methods for their production and use | RESEARCH TRIANGLE INSTITUTE (US) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199536-A1 | Compounds having unique CB1 receptor binding selectivity and methods for their production and use | CNR1, CNR2, GPR18 | HTR3E 301/4885HTR3B 45/4885HTR3A 64/4885 |
| US-11145829-B2 | Organic electroluminescent device, organic electroluminescent display device including the same, and organometallic compound for organic electroluminescent device | L1CAM, OCIAD1, USE1 | HTR3E 3852/4885HTR3B 3960/4885HTR3A 3562/4885 |
| US-20190245154-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE INCLUDING THE SAME, AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | L1CAM, OCIAD1, USE1 | HTR3E 3852/4885HTR3B 3960/4885HTR3A 3562/4885 |
| US-20130172561-A1 | SYNTHESIS OF CYCLOMETALLATED PLATINUM(II) COMPLEXES | OCIAD2, OCIAD1, PDCD2L | HTR3E 4178/4885HTR3B 2650/4885HTR3A 3372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.